Unknown

Dataset Information

0

Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.

ABSTRACT:

SUBMITTER: Barouch DH 

PROVIDER: S-EPMC8314733 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19.
| S-EPMC8282116 | biostudies-literature
Unknown Status of Humoral and Cellular Immune Responses within 12 Months following CoronaVac Vaccination against COVID-19.
| S-EPMC9239277 | biostudies-literature
Unknown Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection.
| S-EPMC10027912 | biostudies-literature
Unknown Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 months.
| S-EPMC12066321 | biostudies-literature
Unknown Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.
| S-EPMC8063883 | biostudies-literature
Unknown Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S.
| S-EPMC9258461 | biostudies-literature
Unknown Decline of Humoral and Cellular Immune Responses Against SARS-CoV-2 6 Months After Full BNT162b2 Vaccination in Hospital Healthcare Workers.
| S-EPMC8926062 | biostudies-literature
Unknown Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers.
| S-EPMC9384313 | biostudies-literature
Unknown SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.
| S-EPMC8497464 | biostudies-literature
Unknown Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.
| S-EPMC10055608 | biostudies-literature